Anti-tumor vaccine derived from normal chemically modified cells

Details for Australian Patent Application No. 2008203730 (hide)

Owner Cytovac A/S

Inventors Dzhandzhugazyan, Karine; Kirkin, Alexei

Agent Pizzeys

Pub. Number AU-A-2008203730

PCT Pub. Number WO2008/081035

Priority 0700058.1 03.01.07 GB

Filing date 3 January 2008

Wipo publication date 10 July 2008

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 July 2009 PCT application entered the National Phase

  PCT publication WO2008/081035 Priority application(s): WO2008/081035

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008203743-Thioxanthene derivates useful to treat infectious diseases

2008203713-Method and apparatus for liquefying a hydrocarbon stream